COMPARATIVE STUDY
JOURNAL ARTICLE
RANDOMIZED CONTROLLED TRIAL
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Short- and long-term effects of continuous versus intermittent restrictive diet approaches on body composition and the metabolic profile in overweight and obese postmenopausal women: a pilot study.

OBJECTIVE: The objective of this study was to compare changes in body composition and the metabolic profile between women taking an intermittent diet (ID) and women taking a continuous diet (CD).

METHODS: Twenty-five obese postmenopausal women were randomized to an ID (n = 13) or a CD (n = 12). In the ID, 5-week energy restriction periods were followed by 5-week weight stabilization periods. In the CD, 15 weeks of energy restriction was followed by 5 weeks of weight stabilization. Outcome measures before, during, and after weight loss, as well as after a 1-year follow-up, were body weight and composition, waist circumference, resting metabolic rate, and fasting lipid and glucose levels.

RESULTS: Body weight, waist circumference, percentage fat mass, and fat mass decreased significantly and similarly in both groups (P < 0.0001). Both groups showed similar overall decreases in plasma total cholesterol and triglycerides (all P < 0.05). Low-density lipoprotein cholesterol improved significantly in the CD group only, whereas fasting glucose decreased significantly in the ID group only. High-density lipoprotein cholesterol and resting metabolic rate remained stable in both groups. Fasting plasma triglyceride and glucose levels were the only metabolic variables to further improve after the fifth week of the protocol. At the 1-year follow-up, both interventions were associated with successful and similar weight loss maintenance and improvements in fasting plasma glucose levels.

CONCLUSIONS: The ID resulted in similar short- and long-term changes in body composition and metabolic profile compared with a CD. Most improvements occurred during the first 5 weeks of treatment in both interventions.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app